Testing after diagnosis of clear cell cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is for people who have been diagnosed with clear cell cancer of the cervix. It looks at cancer tissue and related lab tests to better understand the disease and possibly guide care decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of clear cell carcinoma (a specific type of cervical cancer).
- Your cervical cancer diagnosis is at MD Anderson Cancer Center (MDACC).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, quick diagnostic test for HPV (the virus that can cause cervical cancer). Researchers want to see if the test works well compared to regular tests. If you are due for an HPV test or a related procedure, this study may be a good fit.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This trial tests a personalized blood test that looks for tumor DNA to monitor cervical cancer and help guide treatment decisions. It is for people with advanced or returning cervical cancer who haven't started treatment yet.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Hear when a new Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.